Internationales Congress Centrum (ICC Berlin)
Hall 15.2
11:00-13:00
Berlin, Germany

Chair
Michael Gnant, MD
Medical University of Vienna
Vienna, Austria


Faculty Members
Angelo Di Leo, MD, PhD
Hospital of Prato
Prato, Italy

Joseph Gligorov, MD
Tenon Hospital
Paris, France

Julie Gralow, MD
Seattle Cancer Care Alliance Seattle
Washington, United States

Henning Mouridsen, MD, PhD
Copenhagen University Hospital
Copenhagen, Denmark

Sunday, 20 September 2009
13.00	Welcome and Introduction Michael Gnant, MD
11.00	Managing Endocrine-Responsive Breast Cancer: Have All the Necessary Questions Been Asked to Guide Us Forward? Henning Mouridsen, MD, PhD
11.20	Reassessing Adjuvant Systemic Therapy for Early Breast Cancer Michael Gnant, MD
11.40	Faculty Panel
11.50	Anthracyclines as a Component of Adjuvant Chemotherapy: For Which Patients is this Necessary and Appropriate? Julie Gralow, MD
12.10	Novel Strategies for the Management of Disease Progression Following Standard Chemotherapy Angelo Di Leo, MD
12.30	HER2-Amplified Breast Cancer: Refining Our Approach to Achieve Clinical Outcomes Joseph Gligorov, MD
12.50	Faculty Panel
13.00	Concluding Remarks Michael Gnant, MD